liposomal glutathione parkinson& 39 Innovative approach in Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Research progress on intranasal treatment
Research progress on intranasal treatment for Parkinson's disease Neuroprotection Enhancing drug bioavailability for Parkinson's disease: The promise of chitosan delivery mechanisms ScienceDirect Frontiers Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives Frontiers Medicinefood homology bioactives in Parkinson's disease: multi target oxidative stress modulation and translation to dietary supplements Revamping Parkinson's disease therapy using PLGA based drug delivery systems PMC
Pay in 4 interest-free payments of $6.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




